CD8A and neoplasm: In this study, we investigated the relationships between the IHC subtype of SCLC, HLA-class I expression in the tumor or infiltration of CD8-positive CTLs into the tumor, and patient survival (PFS and OS) utilizing FFPE specimens from patients diagnosed with ED-SCLC and treated with chemotherapy and/or ICIs as initial therapy.